1. Wallace JL, Cirino G. The development of gastrointestinal-sparing nonsteroidal anti-inflammatory drugs. TIPS. 1994;15:405–6.
2. Vane JR, Botting RM. New insights into the mode of action of anti-inflammatory drugs. Inflamm Res. 1995;44:l-10.
3. Seibert K, Masferrer J, Zhang Y, et al. Expression and selective inhibition of constitutive and inducible forms of cyclooxygenase. In: Samuelsson B, Ramwell PW, Paoletti R, Folco G, Granstrom E, Nicosia S, eds. Advances in Prostaglandin, Thromboxane and Leukotriene Research, Vol. 23. New York: Raven Press; 1995:125–7.
4. Vane JR, Botting RM. A better understanding of anti-inflammatory drugs based on isoforms of cyclooxygenase (COX-1 and COX-2). In: Samuelsson B, Ramwell PW, Paoletti R, Folco G, Granstrom E, Nicosia S, eds. Advances in Prostaglandin, Thromboxane and Leukotriene Research, Vol. 23. New York: Raven Press; 1995:41.
5. Laneuville O, Breuer DK, Dewitt DL, Hla T, Funk CD, Smith WL. Differential inhibition of human prostaglandin endoperoxide H synthases-1 and -2 by nonsteroidal anti-inflammatory drugs. J Pharmacol Exp Ther. 1994;271:927–34.